Compare iShares iBoxx $ High Yield Corporate Bond ETF (HYG) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ High Yield Corporate Bond ETF vs Koninklijke Philips NV — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.65, while Koninklijke Philips NV trades at $26.77 (market cap $26.19B). The key difference: Koninklijke Philips NV pays a 3.79% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| HYG | PHG | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $81.32 | $32.91 |
52-Week Low | $78.72 | $24.54 |
Market Cap | — | $26.19B |
Enterprise Value | — | $32.46B |
Dividend Yield | — | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HYG trades at $79.68 with minimal daily movement, showing a slight gain of 0.04%. Technical indicators are bearish overall, with moving averages signaling sell pressure and oscillators neutral. Recent dividends include H1-26 payments of $0.41 and $0.42, with another $0.37 scheduled for H2-26. Bond ETF inflows are surging, with $300 billion reported by Benzinga on July 20, 2026, as higher yields attract income-seeking investors.
The outlook remains cautious due to bearish technical signals and Fed rate uncertainty. Opportunities exist from strong bond ETF demand, but risks include potential rate hikes and high-yield sector volatility. CNBC reported on June 18, 2026, elevated put volume against HYG, indicating bearish bets. Investors should weigh yield appeal against macroeconomic headwinds.
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
